Royalty Pharma PLC (RPRX)
NASDAQ
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 0.681 | 12.173 | 3.696 | 0.25 | 6.837 |
Return on Equity (%) | 0.681 | 19.706 | 6.153 | 0.433 | 11.574 |
Return on Invested Capital (%) | -28.173 | 137.563 | 55.912 | 44.877 | 120.062 |
Operating Margin (%) | N/A | 1296.546 | 821.816 | 1115.209 | 226020.958 |
Net Profit Margin (%) | N/A | 680.03 | 361.889 | 114.267 | 135908.263 |
Book Value Per Share | 41.146 | 7.652 | 7.677 | 7.139 | 7.483 |
Earnings Per Share | 0.14 | 0.756 | 0.464 | 0.032 | 0.842 |
Cash Per Share | 0.243 | 0.782 | 1.155 | 1.282 | 0.354 |
Working Capital Per Share | 0.267 | 1.853 | 2.029 | 1.04 | 0.826 |
Operating Profit Per Share | N/A | 1.646 | 1.716 | 1.677 | 1.747 |
EBIT Per Share | 0.14 | 1.32 | 0.93 | 0.172 | 1.261 |
EBITDA Per Share | 0.14 | 1.32 | 0.93 | 0.172 | 1.261 |
Free Cash Flow Per Share | 0.14 | 0.738 | 0.661 | 0.278 | 1.108 |
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 365.9M | N/A | N/A | N/A | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 81.296 | N/A | N/A | N/A | 7.035 | N/A | N/A |
Net Profit Margin (%) | N/A | 49.82 | N/A | N/A | N/A | 0.841 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 15.44B |
Price to Earnings Ratio | 15.32 |
Price to Sales Ratio | 7.38 |
Price to Cash Ratio | 36.44 |
Price to Book Ratio | 1.72 |
Dividend Yield | 67.82% |
Shares Outstanding | 589.18M |
Average Volume (1 week) | 2.31M |
Average Volume (1 Month) | 3M |
52 Week Change | 4.21% |
52 Week High | 31.655 |
52 Week Low | 24.05 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.